Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease

NCT01042509 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease

Interventions

DRUG: Alemtuzumab and rituximab

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez